Figure (Cis0d 0001 01)
Cisplatin
Product Images NDC 65219-359
10 FDA label images from Fresenius Kabi Usa, Llc · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Cisplatin (NDC 65219-359). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure (Cis0d 0001 02)
Figure (Cis0d 0001 03)
Cisplatin Injection 50 mg per 50 mL (1 mg per mL) vial label from Fresenius Kabi USA, LLC. The label includes warnings about dosage and cytotoxicity, directions for intravenous use, and emphasizes verifying drug name and dose before administration. The vial is indicated for single use.*
Figure (Cis0d 0001 04)
Box packaging label for Cisplatin Injection BP 1 mg/ml KEOMPLAT by Fresenius Kabi USA, LLC. The label indicates a 50 mg/50 ml single dose vial with instructions for intravenous use and storage conditions. The package also includes warnings about cytotoxicity and proper handling precautions.*
Figure (Cis0d 0001 05)
Cisplatin Injection 50 mg per 50 mL (1 mg per mL) vial label by Fresenius Kabi USA, LLC. The label highlights that the cisplatin dose greater than 100 mg/m² once every 3-4 weeks is rarely used. The packaging indicates the product is a cytotoxic agent for intravenous use, supplied as a multiple dose vial containing 50 mg.*
Figure (Cis0d 0001 06)
Label for Cisplatin Injection BP 1 mg/ml, 50 mg/50 ml, a single-dose vial by Fresenius Kabi USA, LLC. The label shows detailed ingredients, warnings, storage instructions, and preparation directions for this chemotherapy medication in a 50 ml vial.*
Figure (Cis0d 0001 07)
Cisplatin Injection 50 mg per 50 mL in a 50 mL amber glass vial with a purple cap. The label shows the proprietary name 'CISplatin' prominently, strength and volume, and manufacturer Fresenius Kabi USA, LLC. The vial is intended for injection use.*
Figure (Cis0d 0001 08)
Cisplatin Injection EP 1 mg/mL in a 50 mL glass vial labeled Kemoplat by Fresenius Kabi USA, LLC. The vial label indicates a concentration of 50 mg/50 mL and specifies single dose use.*
Package Label – Principal Display Panel – Cisplatin Injection 50 mL Carton Panel (Cis0d 0001 09)
Packaging label for Cisplatin Injection BP 1 mg/ml, 50 mg/50 ml single dose vial, branded as KEMOPLAT. The label includes dosage strength, volume, and manufacturer name Fresenius Kabi. It highlights that the product contains no antimicrobial preservatives and is for intravenous infusion after dilution. Storage and safety warnings, including cytotoxicity and breastfeeding precautions, are also present.*
Package Label – Principal Display Panel – Cisplatin Injection 50 mL Vial Label (Cis0d 0001 10)
Cisplatin Injection BP 1 mg/ml in a single-dose 50 ml vial labeled Kemoplat by Fresenius Kabi USA, LLC. The label highlights preparation instructions, dosage directions, and warnings including use only under medical supervision, contraindication during breastfeeding, and storage conditions. It states no antimicrobial preservatives and is indicated as a cytotoxic agent for intravenous infusion after dilution.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
